Recombinant VEGFR2/CD309 antibody

Catalog No. ABIN1589715

This anti-VEGFR2/CD309 antibody is a Mouse Monoclonal antibody detecting VEGFR2/CD309 in ELISA and FACS. Suitable for Human.

Quick Overview for Recombinant VEGFR2/CD309 antibody (ABIN1589715)

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Antibody Type: Recombinant Antibody

Fragment: scFv fragment

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This VEGFR2/CD309 antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Product Details anti-VEGFR2/CD309 Antibody

Expression System: Escherichia coli (E. coli)

Purpose: VEGFR-2/sc-Fv (single chain) antibody

Characteristics: Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.

Application Details

Application Notes: FACS: Use at 0.5-5 μg/mL, ELISA

Restrictions: For Research Use only

Handling

Format: Frozen

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: 150 mM NaCl, 150 mM NaP, pH 7.2

Storage: -20 °C,-80 °C

Storage Comment: The single chain antibody is supplied as frozen liquid (concentration please see vial label). For long time storage we recommend storage at -20°C to -70°C.

Expiry Date: 24 months

Target Details for VEGFR2/CD309

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Alternative Name: VEGFR-2

Background: Vascular endothelial growth factor receptor-2 , KDR, FLK1, CD309, VEGF receptor 2, kinase insert domain protein receptor,Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.

Gene ID: 3791

NCBI Accession: NM_002253, NP_002244

UniProt: P35968

Pathways: RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling